The Plant Protease Inhibitor EcTI Suppresses Melanoma Progression In Vivo
Molecules · 13.08.2026 · 31 (16) · 2829
DOI: 10.3390/molecules31162829 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 13.08.2026. Verfasst von Camila Ramalho Bonturi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Universidade Federal de São Paulo (UNIFESP), São Paulo 04044-020, SP, Brazil. Hauptthemen laut MEDLINE: Protease Inhibitors, Melanoma, Melanoma, Experimental. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, Coordenação de Aperfeicoamento de Pessoal de Nível Superior, National Council for Scientific and Technological Development.
Abstract (Originalsprache)
Melanoma dissemination depends on tumor cell plasticity, extracellular matrix remodeling, and adaptive signaling pathways that promote survival, migration, invasion, and therapeutic resistance. In this study, we investigated the antitumor effects of the plant-derived Kunitz-type protease inhibitor EcTI using both in vitro B16F10-Nex2 melanoma cells and an in vivo murine melanoma model, focusing on adhesion-dependent signaling, autophagy, mitochondrial dysfunction, and regulated cell death. EcTI was efficiently internalized by melanoma cells and showed partial colocalization with lysosomal and mitochondrial compartments, suggesting intracellular trafficking toward these organelles. Treatment reduced cell adhesion to extracellular matrix proteins, particularly fibronectin and laminin, and inhibited migration, invasion, and angiogenic signaling. These effects were associated with modulation of the adhesion-dependent FAK/Src/ERK signaling axis and decreased MMP-9 activity. EcTI also disrupted autophagy, as indicated by accumulation of acidic vesicular organelles, increased LC3-II levels, and modulation of ULK1, Ambra1, and Beclin-1 signaling. In parallel, EcTI induced mitochondrial dysfunction, characterized by loss of mitochondrial membrane potential, intracellular Ca2+ dysregulation, and increased reactive oxygen species production. These alterations triggered regulated cell death involving apoptotic and necroptosis-like mechanisms. Importantly, EcTI significantly suppressed tumor growth in vivo without detectable systemic toxicity and modulated inflammatory mediators associated with tumor progression. Overall, these findings demonstrate that EcTI exerts broad antitumor activity by modulating multiple signaling pathways associated with melanoma progression and represents a promising therapeutic candidate for melanoma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Universidade Federal de São Paulo (UNIFESP), São Paulo 04044-020, SP, Brazil.
- Electron Microscopy Center, Universidade Federal de São Paulo (UNIFESP), São Paulo 04044-020, SP, Brazil.
- Centre of Excellence in New Target Discovery (CENTD), Instituto Butantan, São Paulo 05503-900, SP, Brazil.
- Department of Physiological Sciences, Universidade Federal de São Carlos, Rodovia Washington Luis, Km 235, São Carlos 13565-905, SP, Brazil.
ORCID-Profile: Camila Ramalho Bonturi, Márcia Bonini, Rita de Cassia Sinigaglia, Miryam Paola Alvarez-Flores, Ana Marisa Chudzinski-Tavassi, Heloisa Sobreiro Selistre-de-Araujo, Maria Luiza Vilela Oliva
Förderung
- São Paulo Research Foundation
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- National Council for Scientific and Technological Development
- Coordination for the Improvement of Higher Education Personnel
Zitieren
APA
Bonturi, C. R., Salu, B. R., Lie, K. C. M., Bonini, M., Sinigaglia, R. C., Alvarez-Flores, M. P., Chudzinski-Tavassi, A. M., Selistre-de-Araujo, H. S., & Oliva, M. L. V. (2026). The Plant Protease Inhibitor EcTI Suppresses Melanoma Progression In Vivo. Molecules, 31(16), 2829. https://doi.org/10.3390/molecules31162829
Vancouver
Bonturi CR, Salu BR, Lie KCM, Bonini M, Sinigaglia RC, Alvarez-Flores MP, et al. The Plant Protease Inhibitor EcTI Suppresses Melanoma Progression In Vivo. Molecules. 2026;31(16):2829. doi:10.3390/molecules31162829
BibTeX
@article{Bonturi2026,
author = {Bonturi, Camila Ramalho and Salu, Bruno Ramos and Lie, Kathleen Chwen Ming and Bonini, Márcia and Sinigaglia, Rita de Cassia and Alvarez-Flores, Miryam Paola and Chudzinski-Tavassi, Ana Marisa and Selistre-de-Araujo, Heloisa Sobreiro and Oliva, Maria Luiza Vilela},
title = {The Plant Protease Inhibitor EcTI Suppresses Melanoma Progression In Vivo},
journal = {Molecules},
year = {2026},
volume = {31},
number = {16},
pages = {2829},
doi = {10.3390/molecules31162829}
}
EUVIMED